|
Winship Cancer Institute Cancer Center Support Grant
|
3P30CA138292-10S1
|
$72,918
|
$1,458
|
CURRAN, WALTER
|
EMORY UNIVERSITY
|
|
Winship Cancer Institute Cancer Center Support Grant
|
3P30CA138292-10S2
|
$200,473
|
$4,009
|
CURRAN, WALTER
|
EMORY UNIVERSITY
|
|
Winship Cancer Institute Cancer Center Support Grant
|
3P30CA138292-10S3
|
$234,000
|
$4,680
|
CURRAN, WALTER
|
EMORY UNIVERSITY
|
|
Winship Cancer Institute Cancer Center Support Grant
|
5P30CA138292-10
|
$2,574,000
|
$51,480
|
CURRAN, WALTER
|
EMORY UNIVERSITY
|
|
UW Comprehensive CANCER CENTER SUPPORT
|
2P30CA014520-44
|
$4,590,130
|
$45,901
|
BAILEY, HOWARD
|
UNIVERSITY OF WISCONSIN-MADISON
|
|
UW Comprehensive CANCER CENTER SUPPORT
|
3P30CA014520-44S1
|
$250,000
|
$2,500
|
BAILEY, HOWARD
|
UNIVERSITY OF WISCONSIN-MADISON
|
|
UW Comprehensive CANCER CENTER SUPPORT
|
3P30CA014520-44S2
|
$136,232
|
$1,362
|
BAILEY, HOWARD
|
UNIVERSITY OF WISCONSIN-MADISON
|
|
UW Comprehensive CANCER CENTER SUPPORT
|
3P30CA014520-44S3
|
$75,711
|
$757
|
BAILEY, HOWARD
|
UNIVERSITY OF WISCONSIN-MADISON
|
|
UW Comprehensive CANCER CENTER SUPPORT
|
3P30CA014520-44S4
|
$31,772
|
$318
|
BAILEY, HOWARD
|
UNIVERSITY OF WISCONSIN-MADISON
|
|
Using donor pDC to optimize GvHD and GvL in allogeneic stem cell transplantation
|
5R01CA188523-05
|
$323,700
|
$323,700
|
WALLER, EDMUND
|
EMORY UNIVERSITY
|
|
USC Norris Comprehensive Cancer Center (Core) Grant
|
3P30CA014089-43S1
|
$40,593
|
$406
|
FARNHAM, PEGGY
|
UNIVERSITY OF SOUTHERN CALIFORNIA
|
|
USC Norris Comprehensive Cancer Center (Core) Grant
|
5P30CA014089-43
|
$6,268,475
|
$62,685
|
FARNHAM, PEGGY
|
UNIVERSITY OF SOUTHERN CALIFORNIA
|
|
UNIVERSITY OF MARYLAND GREENEBAUM CANCER CENTER SUPPORT GRANT
|
3P30CA134274-11S1
|
$629,550
|
$25,182
|
CULLEN, KEVIN
|
UNIVERSITY OF MARYLAND BALTIMORE
|
|
UNIVERSITY OF MARYLAND GREENEBAUM CANCER CENTER SUPPORT GRANT
|
3P30CA134274-11S2
|
$200,000
|
$8,000
|
CULLEN, KEVIN
|
UNIVERSITY OF MARYLAND BALTIMORE
|
|
UNIVERSITY OF MARYLAND GREENEBAUM CANCER CENTER SUPPORT GRANT
|
3P30CA134274-11S3
|
$125,000
|
$5,000
|
CULLEN, KEVIN
|
UNIVERSITY OF MARYLAND BALTIMORE
|
|
UNIVERSITY OF MARYLAND GREENEBAUM CANCER CENTER SUPPORT GRANT
|
5P30CA134274-11
|
$2,266,216
|
$90,649
|
CULLEN, KEVIN
|
UNIVERSITY OF MARYLAND BALTIMORE
|
|
Understanding and predicting relapse in acute myeloid leukemia
|
2R01CA175008-06
|
$418,000
|
$418,000
|
RADICH, JERALD
|
FRED HUTCHINSON CANCER RESEARCH CENTER
|
|
TRAINING IN CANCER BIOLOGY AND TRANSPLANTATION
|
5T32CA009515-34
|
$666,666
|
$166,667
|
DAVIDSON, NANCY
|
UNIVERSITY OF WASHINGTON
|
|
The Tisch Cancer Institute - Cancer Center Support Grant
|
3P30CA196521-04S1
|
$249,999
|
$20,000
|
PARSONS, RAMON
|
ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI
|
|
The Tisch Cancer Institute - Cancer Center Support Grant
|
3P30CA196521-04S2
|
$224,981
|
$17,998
|
PARSONS, RAMON
|
ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI
|
|
The Tisch Cancer Institute - Cancer Center Support Grant
|
5P30CA196521-04
|
$2,373,000
|
$189,840
|
PARSONS, RAMON
|
ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI
|
|
The Role of Trisomy 21 in Hematopoiesis and Leukemogenesis
|
5F31CA196231-04
|
$31,044
|
$15,522
|
LIGGETT, LUTHER
|
UNIVERSITY OF COLORADO DENVER
|
|
The role of intestinal microbiota in graft-versus-host disease
|
1R01CA228308-01
|
$525,957
|
$525,957
|
VAN DEN BRINK, MARCEL
|
SLOAN-KETTERING INST CAN RESEARCH
|
|
The role and functional mechanism of TET1 in MLL-rearranged leukemia
|
5R01CA178454-07
|
$369,725
|
$184,863
|
CHEN, JIANJUN
|
BECKMAN RESEARCH INSTITUTE/CITY OF HOPE
|
|
The Promoting Resilience in Stress Management (PRISM) Intervention: a multi-site randomized controlled trial for Adolescents and Young Adults receiving Hematopoietic Cell Transplantation
|
1R01CA225629-01
|
$524,411
|
$524,411
|
ROSENBERG, ABBY
|
SEATTLE CHILDREN'S HOSPITAL
|
|
The impact of cell-specific deletion of MHC class I in generating glioma-specific T cell responses
|
1F31CA221336-01A1
|
$22,086
|
$7,288
|
MALO, COURTNEY
|
MAYO CLINIC ROCHESTER
|
|
The impact of aging-associated chronic inflammation on the selection for oncogenic driver mutations in hematopoietic stem cells
|
5F30CA210383-03
|
$41,416
|
$20,708
|
HIGA, KELLY
|
UNIVERSITY OF COLORADO DENVER
|
|
The contribution of the innate immune sensor STING in GVHD and GVL following allogeneic hematopoietic stem cell transplantation
|
1F31CA216999-01A1
|
$44,524
|
$44,524
|
BADER, CAMERON
|
UNIVERSITY OF MIAMI SCHOOL OF MEDICINE
|
|
Targeting novel DAMP mediated signaling pathways to mitigate GVHD
|
5R01CA217156-02
|
$429,228
|
$429,228
|
REDDY, PAVAN
|
UNIVERSITY OF MICHIGAN AT ANN ARBOR
|
|
Targeting Granzyme B to Separate GVH from GVL Responses
|
5R01CA184728-05
|
$353,419
|
$353,419
|
CAO, XUEFANG
|
UNIVERSITY OF MARYLAND BALTIMORE
|
|
Targeting Cdc42 for bone marrow transplant therapies
|
5R01CA193350-04
|
$356,850
|
$356,850
|
ZHENG, YI
|
CINCINNATI CHILDRENS HOSP MED CTR
|
|
Targeted therapy of B cell malignances with CAR-T cells of defined composition
|
5R01CA136551-10
|
$560,424
|
$280,212
|
RIDDELL, STANLEY
|
FRED HUTCHINSON CANCER RESEARCH CENTER
|
|
Targeted Alpha Radioimmunotherapy with Haploidentical Bone Marrow Transplantation for AML
|
5K01CA188151-04
|
$169,020
|
$169,020
|
OROZCO, JOHNNIE
|
FRED HUTCHINSON CANCER RESEARCH CENTER
|
|
Study of the Roles of SDF1 and CXCR4 in Hematopoiesis
|
ZIA BC 010782
|
$366,567
|
$183,284
|
Tosato, Giovanna
|
CCR (NCI)
|
|
Stem Cell-Adrenomedullin Therapy for Cancer Linked Lymphedema
|
5R21CA201940-03
|
$109,038
|
$54,519
|
HU, MICKEY
|
PANORAMA RESEARCH, INC.
|
|
Statin Intervention to Slow the Time to Hepatocellular Carcinoma Recurrence in Cirrhotics Awaiting Liver Transplantation
|
5R01CA218486-02
|
$661,266
|
$661,266
|
HUSSAIN, SHEHNAZ
|
CEDARS-SINAI MEDICAL CENTER
|
|
Stanford Cancer Institute
|
3P30CA124435-11S1
|
$248,520
|
$4,970
|
ARTANDI, STEVEN
|
STANFORD UNIVERSITY
|
|
Stanford Cancer Institute
|
3P30CA124435-11S2
|
$171,518
|
$3,430
|
ARTANDI, STEVEN
|
STANFORD UNIVERSITY
|
|
Stanford Cancer Institute
|
5P30CA124435-11
|
$3,334,464
|
$66,689
|
ARTANDI, STEVEN
|
STANFORD UNIVERSITY
|
|
SPORE in Myeloid Malignancies
|
5P50CA206963-02
|
$2,300,000
|
$138,000
|
EBERT, BENJAMIN
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
Specialized Program Of Research Excellence (SPORE) in Leukemia.
|
2P50CA171963-06
|
$2,299,839
|
$781,945
|
LINK, DANIEL
|
WASHINGTON UNIVERSITY
|
|
Specialized Program Of Research Excellence (SPORE) in Leukemia.
|
3P50CA171963-06S1
|
$66,323
|
$22,550
|
LINK, DANIEL
|
WASHINGTON UNIVERSITY
|
|
RXR Rexinoids for Cancer Chemoprevention
|
5P01CA210946-02
|
$1,481,363
|
$874,004
|
ELMETS, CRAIG
|
UNIVERSITY OF ALABAMA AT BIRMINGHAM
|
|
Role of ErbB receptor signaling in regulating normal and leukemic stem cell fate
|
5K08CA184552-05
|
$127,865
|
$38,360
|
DOAN, PHUONG
|
DUKE UNIVERSITY
|
|
Randomized Trial of Inpatient Palliative Care for Patients with Hematologic Malignancies Undergoing Hematopoietic Stem Cell Transplantation
|
1R01CA222014-01A1
|
$460,062
|
$460,062
|
EL-JAWAHRI, AREEJ
|
MASSACHUSETTS GENERAL HOSPITAL
|
|
Protective role of Honokiol in preventing c-Met-induced post-transplantation cancer
|
1R01CA222355-01
|
$411,068
|
$411,068
|
PAL, SOUMITRO
|
BOSTON CHILDREN'S HOSPITAL
|
|
Prevention of bone loss after pediatric hematopoietic cell transplantation
|
5R01CA181024-05
|
$477,235
|
$477,235
|
SARAFOGLOU, KYRIAKIE
|
UNIVERSITY OF MINNESOTA
|
|
Pre-clinical Studies of Therapy for Myelodysplastic Syndrome
|
ZIA BC 010983
|
$374,676
|
$187,338
|
Aplan, Peter
|
CCR (NCI)
|
|
Pediatric Oncology Research Training Program
|
5T32CA009351-40
|
$250,143
|
$100,057
|
BERNSTEIN, IRWIN
|
FRED HUTCHINSON CANCER RESEARCH CENTER
|
|
PD-L1 interacts with CD80 and PD-1 to regulate GVHD and GVL activity
|
1R01CA228465-01
|
$404,275
|
$404,275
|
ZENG, DEFU
|
BECKMAN RESEARCH INSTITUTE/CITY OF HOPE
|
Total relevant funding to Organ Transplantation Research for this search: $51,345,908
|